Gastrointestinal cancer trends in the Hispanic population: A SEER database population study (2000-2019).

Authors

null

Sharon Hechter

Hackensack Meridian Health Ocean University Medical Center, Brick, NJ

Sharon Hechter , Ivan Nikiforov , David B. Greenberg

Organizations

Hackensack Meridian Health Ocean University Medical Center, Brick, NJ, Atlantic Hematology Oncology Assocs, Neptune, NJ

Research Funding

No funding received
None.

Background: Cancer continues to be the leading cause of death in the Hispanic population. Gastrointestinal cancer surveillance data in Hispanic individuals has only recently become available in the last 3 decades. Differences in incidence rates among Hispanics and Non-Hispanic Whites (NHWs) need further elucidation. In this study, we analyzed trends in Hispanics and NHW populations across multiple gastrointestinal cancers. Methods: Gastrointestinal cancers (liver, colon and rectum, pancreas, esophagus, gallbladder, stomach, small intestine, anus, anal canal and anorectum) diagnosed between 2000-2019 were identified in the Surveillance, Epidemiology, and End Results Program (SEER) Database. We calculated incidence rates, confidence intervals and incidence rate ratios. Rates are per 100,000 and age adjusted to the 2000 US standard population. Rate ratios are the rounded rates in Hispanic individuals divided by the rounded rates in NHWs. Results: There was a higher incidence of liver, gallbladder, and stomach cancers among Hispanics when compared to NHWs between the years 2000-2019. Liver cancer incidence rate is (11.5 per 100,000) in Hispanics compared with (6.3 per 100, 000) in NHWs with an incidence rate ratio of 1.8. Gallbladder cancer incidence rate is (2.2 per 100,000) in Hispanics compared with (0.9 per 100,000) in NHWs with an incidence rate ratio of 2.4. Stomach cancer is (10.9 per 100,000) in Hispanics compared with (5.7 per 100,000) in NHWs with an incidence rate ratio of 1.9. The lowest incidence rate ratio was seen for anus, anal canal and anorectum cancers in Hispanics compared to NHWs. The incidence rate is (1.2 per 100,000) in Hispanics compared with (2.1 per 100,000) in NHWs with an incidence rate ratio of 0.6. Remaining cancers had incidence rate ratios less than 1.0 and were more likely to occur in NHWs. Conclusions: This study illustrates differing incidence rates of multiple gastrointestinal cancers among Hispanics compared to NHWs. Liver, gallbladder and stomach cancer incidence rates in Hispanics is double that of NHWs. Interestingly, the remaining gastrointestinal cancers had higher incidence rates among NHWs. Further research is warranted to understand the differences in cancer risk within the Hispanic population as well as healthcare access, language barriers and cultural differences that may play a role.

Gastrointestinal cancer incidence rates between 2000-2019.

HispanicNon-Hispanic White
Gastrointestinal CancerRate95% Confidence IntervalRate95% Confidence IntervalRate Ratio
Liver11.5(11.3-11.6)6.3(6.3-6.3)1.8
Pancreas11.3(11.2-11.5)12.3(12.2-12.3)0.9
Colon and Rectum36(35.8-36.3)44(43.8-44)0.8
Gallbladder2.2(2.1-2.2)0.9(0.9-0.9)2.4
Anus, Anal Canal and Anorectum1.2(1.2-1.3)2.1(2.0-2.1)0.6
Stomach10.9(10.8-11.1)5.7(5.7-5.8)1.9
Esophagus2.8(2.7-2.9)4.8(4.7-4.8)0.6
Small Intestine1.6(1.6-1.7)2.2(2.2-2.2)0.7

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2023 ASCO Annual Meeting

Session Type

Publication Only

Session Title

Publication Only: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Other GI Cancer

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr e16331)

DOI

10.1200/JCO.2023.41.16_suppl.e16331

Abstract #

e16331

Abstract Disclosures

Similar Abstracts

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Gastrointestinal cancer trends in the Hispanic population: A SEER database population study (2000-2019).

First Author: Sharon Hechter

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Prevalence of modifiable risk factors of Hispanic adult patients admitted with gastric cancer in the US.

First Author: Alejandro Nieto Dominguez

Abstract

2023 ASCO Gastrointestinal Cancers Symposium

Lower risk of metabolic syndrome and fatty liver in gastric cancer survivors: A propensity score-matched analysis.

First Author: Hyojin Park